Jessica Zeaske, PhD, MBA is a seasoned venture capitalist and board leader in the healthcare industry. She is currently a Partner at Echo Health Ventures in Boston, where she identifies and invests in emerging and growth stage companies in the healthcare, biotech and medtech sectors. She has worked with independent, corporate, and university funds, and written dozens of investment themes over the years.

Zeaske completed her undergraduate degree with honors from Stanford University before studying Health Policy and Management at Johns Hopkins Bloomberg School of Public Health where she earned both a Master’s Degree and a PhD. She then went on to earn her MBA with a focus on Healthcare Administration and Management from Regis University.

Zeaske sits on the Board of Directors for several companies including Avalon Healthcare Solutions, Genome Medical and Wildflower Health, and serves on the Board of DentaQuest Partnership for Oral Health Advancement. She also serves as a Trustee for Boston Medical Center's Exceptional Care Without Exception Trust, is an Advisory Board member for Boston Children's Hospital, and is a member of the National Association of Corporate Directors.

Throughout her career, Zeaske has gained experience in healthcare investments, market disruption in healthcare services, and intellectual property-based company formation and spinning out of MedTech and Life Science companies.